ABEONA THERAPEUTICS INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Abeona Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Abeona Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -72.2 %, a 4.23% increase year-over-year.
  • Abeona Therapeutics Inc. annual Return On Assets for 2023 was -91.5 %, a 16.9% decline from 2022.
  • Abeona Therapeutics Inc. annual Return On Assets for 2022 was -78.3 %, a 8.44% decline from 2021.
  • Abeona Therapeutics Inc. annual Return On Assets for 2021 was -72.2 %, a 39.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -72.2 +3.19 +4.23% Jul 1, 2024 Sep 30, 2024
Q2 2024 -62.1 +12.9 +17.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -119 -65.4 -123% Jan 1, 2024 Mar 31, 2024
Q4 2023 -91.5 -13.2 -16.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -75.4 +69.9 +48.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -74.9 +32.1 +30% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.2 +41.4 +43.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -78.3 -6.09 -8.44% Oct 1, 2022 Dec 31, 2022
Q3 2022 -145 -105 -264% Jul 1, 2022 Sep 30, 2022
Q2 2022 -107 -69.8 -187% Apr 1, 2022 Jun 30, 2022
Q1 2022 -94.7 -60.9 -180% Jan 1, 2022 Mar 31, 2022
Q4 2021 -72.2 -20.3 -39.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -39.9 +7.1 +15.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -37.3 +16.6 +30.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -33.8 +26.7 +44.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -51.8 -7.73 -17.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -47 +1.13 +2.35% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.8 -7.59 -16.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.5 -21.7 -56% Jan 1, 2020 Mar 31, 2020
Q4 2019 -44.1 -10.7 -31.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.1 -20.2 -72.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -46.3 -22.5 -95.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -38.8 -14.9 -62.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -33.5 -10.5 -45.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -28 -2.64 -10.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -23.7 +0.23 +0.96% Apr 1, 2018 Jun 30, 2018
Q1 2018 -23.9 -0.16 -0.68% Jan 1, 2018 Mar 31, 2018
Q4 2017 -22.9 +3.07 +11.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -25.3 -2.78 -12.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -23.9 +1.79 +6.96% Apr 1, 2017 Jun 30, 2017
Q1 2017 -23.7 -1.38 -6.19% Jan 1, 2017 Mar 31, 2017
Q4 2016 -26 -3.63 -16.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -22.5 +26.7 +54.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -25.7 +47.3 +64.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -22.3 +347 +94% Jan 1, 2016 Mar 31, 2016
Q4 2015 -22.4 +587 +96.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -49.2 +3.9K +98.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -73.1 +2.34K +97% Apr 1, 2015 Jun 30, 2015
Q1 2015 -370 -327 -762% Jan 1, 2015 Mar 31, 2015
Q4 2014 -609 -915 -299% Oct 1, 2014 Dec 31, 2014
Q3 2014 -3.95K -5.41K -370% Jul 1, 2014 Sep 30, 2014
Q2 2014 -2.41K -3.01K -501% Apr 1, 2014 Jun 30, 2014
Q1 2014 -42.9 +44.7 +51% Jan 1, 2014 Mar 31, 2014
Q4 2013 306 +796 Oct 1, 2013 Dec 31, 2013
Q3 2013 1.46K +2.59K Jul 1, 2013 Sep 30, 2013
Q2 2013 601 +1.11K Apr 1, 2013 Jun 30, 2013
Q1 2013 -87.6 +67.4 +43.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -490 Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.13K Jul 1, 2012 Sep 30, 2012
Q2 2012 -511 Apr 1, 2012 Jun 30, 2012
Q1 2012 -155 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.